期刊文献+

紫杉醇脂质体联合卡铂治疗老年卵巢癌的效果观察 被引量:3

下载PDF
导出
摘要 目的探索应用紫杉醇脂质体联合卡铂治疗老年卵巢癌的临床疗效。方法将46例老年卵巢癌患者分为23例对照组,采用使用常规化疗后用卡铂治疗;23例治疗组,采用使用常规化疗后用紫杉醇脂质体联合卡铂治疗,观察对比临床疗效。结果治疗组治疗后与对照组指标相比有差异,具有统计学意义(P<0.05,P<0.01);对照组有效率为47.8%,控制率为73.9%,治疗组有效率为78.3%,控制率为91.3%,经统计学分析,两组差异具有统计学意义(P<0.05)。结论采用在常规化疗后使用紫杉醇脂质体联合卡铂治疗老年卵巢癌患者,在临床疗效方面优于采用在常规化疗后使用卡铂治疗,值得在临床治疗上推广。
出处 《中国医药指南》 2013年第28期426-427,共2页 Guide of China Medicine
  • 相关文献

参考文献3

二级参考文献17

  • 1刘斌.紫杉醇新剂型——紫杉醇脂质体(力扑素)临床应用观察[J].中国医院用药评价与分析,2007,7(1):59-60. 被引量:25
  • 2Ozols RF,Bundy BN,Greer BE,et al.Phase Ⅲ trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage Ⅲ ovarian cancer:a Gynecologic Oncology Group study[J].J Clin Oncol,2003;21(17):3194-200.
  • 3Yang T,Cui FD,Choi MK,et al.Liposome formulation of paclitaxel with enhanced solubility and stability[J].Drug Deliv,2007;14(5):301-8.
  • 4Extermann M.Measuring comorbidity in older cancer patients[J].Eur J Cancer,2000;36(4):453-71.
  • 5Vaseg PA,Atkinson R,Coleman R,et al.Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer[J].Br J Cancer,2001;84(2):170-8.
  • 6Yang T,Cui FD,Choi MK,et al.Liposome formulation of paclitaxel with enhanced solubility and stability[J].Drug Deliv,2007.14(5):301-8.
  • 7Connelly E,Markman M,Kennedy A.Paclitaxel delivered as a 3-hr infusion with cisplatine in patients with gynecologic cancers: unexpected incidence of neurotoxicity[].Gynecologic Oncology.1996
  • 8Averette HE,Hoskins W,Nguyen HN.National surgery of ovarian carcinoma: a patient care evaluation of the American college of surgeons[].Cancer.1993
  • 9Yancik R,Ries LG.Cancer in the aged: an epidemiology perspective on treatment issues[].Cancer.1991
  • 10Phoebe Dauz Williams,Kathleen A Ducey.Treatment type and symptom severity among oncology patients by self-report[].International Journal of Nursing Studies.2001

共引文献16

同被引文献17

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部